常全娥,赵立,苟萍

• 1:新疆大学生命科学与技术学院

摘要(Abstract)：

目的通过大蒜素和蒜氨酸+蒜氨酸酶混合物处理高血脂小鼠,比较了它们对高血脂小鼠体重、肝重、肝脏细胞形态和脂肪变性的影响.方法大蒜素与蒜氨酸+蒜氨酸酶混合物处理高血脂小鼠,8周后称量小鼠体重和肝重.制作小鼠肝脏细胞石蜡切片和冰冻切片观察的细胞形态.结果大蒜活性物质大蒜素与蒜氨酸+蒜氨酸酶混合物能抑制高血脂小鼠体重和肝重的增加,降低肝系数,并且具有剂量依赖性.组织学观察表明高剂量大蒜素与蒜氨酸+蒜氨酸酶混合物均能减轻脂质对肝细胞形态的改变.与高血脂模型组相比,高剂量大蒜素与蒜氨酸+蒜氨酸酶混合物处理组肝索排列呈放射状,肝细胞排列较为紧密、规则,细胞核位置接近中央,有细胞界限.细胞内颗粒、脂滴和炎性细胞浸润和肝细胞坏死较少.结论大蒜素和蒜氨酸+蒜氨酸酶混合物能减轻高血脂小鼠脂肪对肝细胞的浸润和脂肪变性,并减轻脂肪对肝小叶和细胞形态的改变.蒜氨酸+蒜氨酸酶混合物在降低高血脂小鼠体重和肝重的效果优于大蒜素.

关键词(KeyWords)： 大蒜素;蒜氨酸;蒜氨酸酶;高血脂;细胞形态

Abstract:

Keywords:

基金项目(Foundation): 新疆维吾尔自治区高校科研计划项目(XJUEDU2010I13)

作者(Author): 常全娥,赵立,苟萍

参考文献(References)：

• [1]Gebhardt R.Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes[J].Lipids,1993,28(7):613-619.
• [2]Liu L J,Yeh Y Y.Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic[J].Lipids,2000,35(2):197-203.
• [3]Yeh Y Y,Liu L J.Cholesterol-lowering effect of garlic extracts and organosulfur compounds:human and animal studies[J].J Nutr,2001,131(3):989S-993S.
• [4]Slowing K,Ganado P,Sanz M,et al.Study of garlic extracts and fractions on cholesterol plasma leves and vascular reactivityin cholesterol-fed rats[J].J Nutr,2001,131(3):994S-999S.
• [5]Agarwal K C.Therapeutic actions of garlic constituents[J].Med Res Rev,1996,16(1):111-124.
• [6]Iciek M,Kwiecien I,Wlodek L.Biological properties of garlic and garlic-derived organosulfur compounds[J].EnvironMutagen,2009,50(3):247-265.
• [7]Davis S R.An overview of the antifungal properties of allicin and its breakdown products-the possibility of a safe andeffective antifungal prophylactic[J].Mycoses,2005,48(2):95-100.
• [8]曾哲灵,熊伟,熊涛,等.大蒜素的提取工艺研究[J].食品与发酵工业,2006,36(2):121-123.
• [9]王秀奇,秦淑媛,高天惠,等.基础生物化学实验[M].高等教育出版社,2003,219-222.
• [10]黄雪松,宴日安.利用新鲜大蒜生产结晶蒜氨酸[J].食品科学,2004,25(11):200-203.
• [11]李强,刘圣红,索菲娅,等.蒜氨酸和蒜氨酸酶的制备及抑菌作用的研究[J].食品科学,2007,28(6):230-233.
• [12]赵肖宪,颜宜茝,傅小锁,等.运动干预对饮食性高胆固醇血症大鼠肝脂肪变的影响[J].中国运动医学杂志,1997,16(3):186-188.
• [13]Horton J D,Goldstein J L,Broen MS.Activators of the complete program of cholesterol and fatty acid synthesis in theliver[J].J Clin Invest,2002,109(9):1125-1131.
• [14]Singh D K,Porter T D.Inhibition of sterol 4α-methyl oxidase is the principal mechanism by which garlicdecreases cholesterolSynthesis[J].J Nutr,2006,136(3):759S-764S.
• [15]Liu L J,Yeh Y Y.S-alk(en)yl cysteines of garlic inhibit cholesterol synthesis by deactivating HMG-CoA reductase incultured rat hepatocytes[J].J Nutr,2002,132(6):1129-1134.
• [16]Espirtto Santo S M,Van Vlijmen BJ,Buytenhek R,et al.Well-characterized garlic-derived materials are not hypolipidemicin APOE*3-leiden transgenic mice[J].J Nutr,2004,134(6):1500-1503.
• [17]Rahman K,Lowe G M.Garlic and cardiovascular Disease:A critical review[J].J Nutr,2006,136(3):736S-740S.